secwatch.observer — SEC 8-K summary
======================================

Issuer:     Vyome Holdings, Inc (HIND)
CIK:        0001427570
Form:       8-K
Filed at:   2022-12-20T23:59:59+00:00
Accession:  0001558370-22-018843
Event type: other_material
Sentiment:  neutral
Materiality: 0.65
Item codes: 5.02, 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

ReShape Lifesciences shareholders approve 2022 equity plan, reverse split, authorized share increase
--------------------------------------------------------------------------------

- Stockholders approved 2022 Equity Incentive Plan with 5,250,000 shares available; effective through Dec 13, 2032.
- Authorized reverse stock split at ratio 1:30 to 1:100, at Board's discretion, valid until Dec 14, 2023.
- Increased authorized common shares to 300,000,000 shares from prior limit.
- Elected Paul F. Hickey as Class III director; votes for 5,366,444 vs withheld 580,976.
- Ratified RSM US LLP as independent auditor for FY2022; votes for 13,866,558.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1427570/000155837022018843/0001558370-22-018843-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1427570/000155837022018843/rsls-20221214x8k.htm
  HTML page:      https://secwatch.observer/filing/0001558370-22-018843

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer